Claritas Pharmaceuticals Inc V.CLAS.H

Is this the reason for the Warrants volume today??

[terrycarter]

https://www.newswire.ca/news-releases/tsx-venture-exchange-stock-maintenance-bulletins-870778760.html KALYTERA THERAPEUTICS INC. ("KLY") BULLETIN TYPE: Warrant Price Amendment, Warrant Term Amendment. Convertible Debenture; Amendment BULLETIN DATE: November 26, 2019 TSX Venture Tier 1 Company Further to a convertible debenture issued pursuant to a private placement originally accepted by the TSX Venture Exchange (the "Exchange") effective April 22, 2019, the Exchange has consented to the amendment of the convertible debenture and associated warrants: Convertible Debenture $787,500 principal amount (less original discount of 5% of purchase price) Original Conversion Price Convertible into Common Share Units ("Units") consisting of one common share and one common share purchase warrant at a price of $0.065 per common share for the first 12-month period following the closing date and $0.10 per Common Share for the second 12-month period following the closing date Amended Conversion Price Convertible into Common Share Units ("Units") consisting of one common share and one common share purchase warrant at a price of $0.05 per common share for one year Original Maturity date 2 years following the closing date Amended Maturity date 1 year following the closing date Original Warrant Terms Each warrant will be exercisable for a period of two years following closing into one common share at a price of $0.065 per common share, provided that if, at any time following the date that is four months following the closing date of the offering, the volume weighted average trading price of the common shares equals or exceeds 13 cents for a period of 20 consecutive trading days, the company may, on prior written notice, accelerate the expiry date of the warrants to the date that is 20 business days from the date of such notice Amended Warrant Terms Each warrant will be exercisable into one common share at a price of $0.05 per common share until March 6, 2020 provided that if, at any time the closing price of the Company's common shares on the Exchange exceeds the exercise price by 25% or more for ten consecutive trading days, then the warrants will expire on the 30th business day calculated from the day that is the seventh calendar day after the last day of the above-mentioned ten day period Original Interest Rate terms 10% per annum Amended Interest Rate terms 10% per annum, payable quarterly only in cash ________________________________________